Achieve Life Sciences Stock Analysis

Achieve Stock Analysis Notes

About 42.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.35. Achieve Life Sciences last dividend was issued on the 31st of July 2020. The entity had 1:20 split on the 31st of July 2020. Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. It has license agreements with Sopharma AD and University of Bristol. Achieve Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. For more info on Achieve Life Sciences please contact Richard Stewart at 604 210 2217 or go to https://www.achievelifesciences.com.

Achieve Life Sciences Investment Alerts

Achieve Life Sciences Upcoming and Recent Events

Achieve Largest EPS Surprises

View All Earnings Estimates

Achieve Life Environmental, Social, and Governance (ESG) Scores

Achieve Stock Institutional Investors

Note, although Achieve Life's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Achieve Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 133.16 M.

Achieve Profitablity

Management Efficiency

Achieve Life Sciences has return on total asset (ROA) of (0.5902) % which means that it has lost $0.5902 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.5455) %, meaning that it created substantial loss on money invested by shareholders. Achieve Life's management efficiency ratios could be used to measure how well Achieve Life manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.14 in 2025. Return On Capital Employed is likely to climb to -1.16 in 2025. At this time, Achieve Life's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 2.2 M in 2025, whereas Other Assets are likely to drop 0.86 in 2025.

Technical Drivers

As of the 21st of July, Achieve Life shows the risk adjusted performance of 0.0865, and Mean Deviation of 5.4. Achieve Life Sciences technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Achieve Life Sciences variance, as well as the relationship between the value at risk and skewness to decide if Achieve Life Sciences is priced correctly, providing market reflects its regular price of 2.68 per share. Please also double-check Achieve Life Sciences total risk alpha, which is currently at (0.44) to validate the company can sustain itself at a future point.

Achieve Life Sciences Price Movement Analysis

Achieve Life Sciences Insider Trading Activities

Achieve Life Outstanding Bonds

Achieve Life Predictive Daily Indicators

Achieve Life Forecast Models

Achieve Life's time-series forecasting models are one of many Achieve Life's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Achieve Life's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Achieve Life prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Achieve shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Achieve Life. By using and applying Achieve Stock analysis, traders can create a robust methodology for identifying Achieve entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Achieve analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Achieve analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Achieve Life Sciences stock analysis indicators help investors evaluate how Achieve Life stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Achieve Life shares will generate the highest return on investment. By understating and applying Achieve Life stock analysis, traders can identify Achieve Life position entry and exit signals to maximize returns.

When running Achieve Life's price analysis, check to measure Achieve Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Achieve Life is operating at the current time. Most of Achieve Life's value examination focuses on studying past and present price action to predict the probability of Achieve Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Achieve Life's price. Additionally, you may evaluate how the addition of Achieve Life to your portfolios can decrease your overall portfolio volatility.